Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia M Wilting

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Cancers|September 28, 2023
Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?Ellis L Eikenboom, Saskia M Wilting, Teoman Deger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2021
Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal MetastasesLindsay Angus, Teoman Deger, Agnes Jager, et al.
Molecular Oncology|June 16, 2026
Longitudinal genome-wide aneuploidy measurements in circulating cell-free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancerYoussra Salhi, Stavros Makrodimitris, Sandra van Wilpe, et al.
Molecular Oncology|February 19, 2022
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancerPauline A J Mendelaar, Debbie G J Robbrecht, Maud Rijnders, et al.
Cancer Research|January 17, 2009
Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomasSaskia M Wilting, Renske D M Steenbergen, Marianne Tijssen, et al.
Scientific Reports|June 27, 2023
Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panelsElisabeth M Jongbloed, Maurice P H M Jansen, Vanja de Weerd, et al.
Breast Cancer Research : BCR|July 2, 2025
A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancerCharlotta V Mulder, Elisabeth M Jongbloed, Marte C Liefaard, et al.
International Journal of Cancer|December 31, 2010
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive womenRenée M Overmeer, Jacqueline A Louwers, Chris J L M Meijer, et al.
Cancers|September 9, 2023
Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER SignalingLindsay Angus, Marcel Smid, Saskia M Wilting, et al.
Eclinicalmedicine|August 21, 2025
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker studyLissa Wullaert, Maurice P H M Jansen, Jaco Kraan, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Cancers|September 28, 2023
Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?Ellis L Eikenboom, Saskia M Wilting, Teoman Deger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2021
Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal MetastasesLindsay Angus, Teoman Deger, Agnes Jager, et al.
Molecular Oncology|June 16, 2026
Longitudinal genome-wide aneuploidy measurements in circulating cell-free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancerYoussra Salhi, Stavros Makrodimitris, Sandra van Wilpe, et al.
Molecular Oncology|February 19, 2022
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancerPauline A J Mendelaar, Debbie G J Robbrecht, Maud Rijnders, et al.
Cancer Research|January 17, 2009
Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomasSaskia M Wilting, Renske D M Steenbergen, Marianne Tijssen, et al.
Scientific Reports|June 27, 2023
Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panelsElisabeth M Jongbloed, Maurice P H M Jansen, Vanja de Weerd, et al.
Breast Cancer Research : BCR|July 2, 2025
A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancerCharlotta V Mulder, Elisabeth M Jongbloed, Marte C Liefaard, et al.
International Journal of Cancer|December 31, 2010
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive womenRenée M Overmeer, Jacqueline A Louwers, Chris J L M Meijer, et al.
Cancers|September 9, 2023
Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER SignalingLindsay Angus, Marcel Smid, Saskia M Wilting, et al.
Eclinicalmedicine|August 21, 2025
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker studyLissa Wullaert, Maurice P H M Jansen, Jaco Kraan, et al.
Pageof 9